质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
ALIFUBATINIB
Rx
肿瘤学 & 血液学

ALIFUBATINIB

富替巴替尼 (Futibatinib)
Generic (INN)
富替巴替尼 (Futibatinib)
Strength
4 mg
Packaging
35片/瓶。
Indication
ALIFUBATINIB 是一种激酶抑制剂，适用于治疗既往接受过治疗的、携带成纤维细胞生长因子受体 2 (FGFR2) 基因融合或其他重排的不可切除、局部晚期或转移性肝内胆管癌成人患者。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALIVEMURA
ALIVEMURA
维莫非尼 (Vemurafenib)
ALIERDATINI 3mg
ALIERDATINI 3mg
厄达替尼 (Erdafitinib)
ALIPONATIB 15mg
ALIPONATIB 15mg
普纳替尼 (Ponatinib)
ALILAZTINI
ALILAZTINI
拉泽替尼 (Lazertinib)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文